Onkologie. 2016:10(4):170-174 | DOI: 10.36290/xon.2016.037

Male breast cancer

Zuzana Bielčiková
Onkologická klinika VFN a 1. LF UK, Praha

Breast cancer in men is a rare disease whose treatment is derived from the treatment of breast cancer in women. It is caused partly

by lack of data, partly by a estimated similarity of the disease in both sexes. New findings on the clinical and biological characteristics

of the male breast cancer should confirm the similarity of female breast cancer or provide evidence that it is a completely

different disease requiring individual approach. Deficiencies in treatment strategies can't be caused by the sex of the patient nor

the incidence of a rare disease. These are reasons why a male breast cancer deserves special attention.

Keywords: male breast cancer, female breast cancer, diagnosis, therapy, follow-up

Published: August 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bielčiková Z. Male breast cancer. Onkologie. 2016;10(4):170-174. doi: 10.36290/xon.2016.037.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Siegel RL, Miller KD, Jemal A, et al. Cancer statistics 2016. CA Cancer J Clin. 2016; 61: 212. Go to original source...
    2. Anderson WF, Althuis MD, Brinton LA, et al. Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat. 2004 Jan; 83(1): 77-86. Go to original source... Go to PubMed...
    3. Cardoso F, Bartlett J, Slaets L, et al. Abstract S6-05: Characterization of male breast cancer: First results of the EORTC10085/TBCRC/BIG/NABCG International Male BC Program. Cancer Res 2015;(75): S6-05. Go to original source...
    4. Ferzoco RM, Ruddy KJ. The epidemiology of male breast cancer. Curr Oncol Rep. 2016 Jan; 18(1): 1. Go to original source...
    5. Thomas DB, Jimenez LM, McTieman A, et al. Breast Cancer In Men: Risk Factors with Hormonal Implications. Am. J. Epidemiol. (1992); 135(7): 734-748. Go to original source... Go to PubMed...
    6. Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet. 2006; 367(9510): 595-604. Go to original source...
    7. Ding YC, Steele L, Kuan CJ, et al. Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States. Breast Cancer Res Treat. 2011 Apr;126(3): 771-778. Go to original source... Go to PubMed...
    8. Silvestri V, Rizzolo P, Zanna I, et al. PALB2 mutations in male breast cancer: a population-based study in Central Italy. Breast Cancer Res Treat. 2010; 122(1): 299. Go to original source... Go to PubMed...
    9. Boyd J, Rhei E, Federici MG, et al. Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat. 1999; 53(1): 87-91. Go to original source... Go to PubMed...
    10. Willsher PC, Leach IH, Ellis IO, et al. Male breast cancer: pathological and immunohistochemical features. Anticancer Res. 1997;17(3C): 2335-2338. Go to PubMed...
    11. Ge Y, Sneige N, Eltorky MA, et al. Immunohistochemical characterization of subtypes of male breast carcinoma. Breast Cancer Res. 2009; 11: R28. Go to original source... Go to PubMed...
    12. Jönsson G, Staaf J, Vallon-Christersson J, et al. Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics. Breast Cancer Res. 2010; 12: R42. Go to original source... Go to PubMed...
    13. Masci G, Caruso M, Caruso F, et al. Clinicopathological and Immunohistochemical Characteristics in Male Breast Cancer: A Retrospective Case Series. Oncologist. 2015; 20(6): 586-92. Go to original source... Go to PubMed...
    14. Goss PE, Reid C, Pintilie M, et al. Male breast carcinoma. A review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer 1999; 85(3): 629-639. Go to original source...
    15. Evans GF, Anthony T, Turnage RH, et al. The diagnostic accuracy of mammography in the evaluation of male breast disease. Am J Surg. 2001; 181(2): 96. Go to original source... Go to PubMed...
    16. Gentilini O, Chagas E, Zurrida S, et al. Sentinel node biopsy in male patients with early breast cancer. The Oncologist 2007; 12(5): 512-515. Go to original source... Go to PubMed...
    17. Zaenger D, Rabatic B, Dasher B, et al. Is Breast Conserving Therapy a Safe Modality for Early-Stage Male Breast Cancer? Clin Breast Cancer. 2016 Apr;16(2): 101-104. Go to original source... Go to PubMed...
    18. Bagshaw HP, Cloyd JM, Poppe MM, et al. Radiation Therapy in Male Breast Cancer. European Oncology & Haematology, 2013;9(2): 119-123. Go to original source...
    19. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-years survival: an overview of the randomised trials. Lancet 2005; 366(9503): 2087-2106. Go to original source...
    20. Shak S, Palmer G, Baehner FL, et al. GW. Molecular characterization of male breast cancer by standardized quantitative RT-PCR analysis: first large genomic study of 347 male breast cancers compared to 82,434 female breast cancers. J Clin Oncol 2009; 27: 549. Go to original source...
    21. Giordano SH, Perkins GH, Broglio K, et al. Adjuvant systemic therapy for male breast carcinoma. Cancer. 2005;104(11): 2359. Go to original source... Go to PubMed...
    22. Eggemann H, Ignatov A, Smith BJ, et al. Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients. Breast Cancer Res Treat. 2013; 137(2):465-70. Go to original source... Go to PubMed...
    23. Cardoso F, Costa A, Norton L, et al. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). Ann Oncol 2014; 1-18. Go to original source...
    24. Petráková K, Palácová M, Schneiderová M, et al. Syndrom hereditárního karcinomu prsu a ovárií. Klin Onkol 2016; 29(Suppl 1): S14-S21. Go to original source... Go to PubMed...
    25. Kantarjian H, Yap HY, Hortobagyi G, et al. Hormonal Therapy for Metastatic Male Breast Cancer. Arch Intern Med. 1983; 143(2): 237-240. Go to original source...
    26. Lopez M, Di Lauro L, Lazzaro B, et al. Hormonal treatment of disseminated male breast cancer. Oncology 1985; 42(6): 345-9. Go to original source...
    27. Di Lauro L, Vici P, Del Medico P, et al. Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer. Breast Cancer Res Treat. 2013; 141(1): 119-23. Go to original source... Go to PubMed...
    28. Di Lauro L, Pizzuti L, Barba M, et al. Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study. J Exp Clin Cancer Res. 2015; 34: 26. Go to original source...
    29. Ottini L, Capalbo C, Rizzolo P, et al. HER2-positive male breast cancer: an update. Breast Cancer 2010;2: 45-58. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.